# Institutional investors’ site visits and investment-cash flow sensitivity: Mitigating financing constraints or inhibiting agent conflicts?

**Authors:** Jia Liao, Yun Zhan, Yu Yuan, Jasman Tuyon, Jasman Tuyon, Jasman Tuyon

PMC · DOI: 10.1371/journal.pone.0300332 · PLOS ONE · 2024-03-28

## TL;DR

This study shows that institutional investors visiting companies can reduce how much investment depends on cash flow, especially in large or poorly governed firms.

## Contribution

The paper reveals that site visits by institutional investors mainly reduce agency-related investment-cash flow sensitivity.

## Key findings

- Institutional site visits reduce investment-cash flow sensitivity, especially in firms with high agency costs.
- The effect is stronger in firms with weak governance and weak executive incentives.
- The impact suggests site visits act as a substitute for other corporate governance mechanisms.

## Abstract

Taking Chinese non-financial A-share companies listed on the Shenzhen Stock Exchange (SZSE) between 2003 and 2018 as a sample, this paper empirically examines whether and how institutional investors’ site visits (SVs) affect corporate investment-cash flow sensitivity (ICFS). The results show that institutional investors’ SVs can reduce ICFS, and this effect is more obvious for companies with fewer investment opportunities, larger sizes, higher internal cash flows, and higher agency costs, indicating that institutional investors’ SVs primarily inhibit ICFS caused by agency conflicts rather than financing constraints. In addition, the inhibitory effect of institutional investors’ SVs on ICFS exists mainly in companies with poor internal supervision governance and weak executive compensation incentive mechanisms, indicating that institutional investors’ SVs and other forms of corporate governance mechanisms operate as substitutes in reducing ICFS. This paper reveals the important role of institutional investors’ SVs in reducing ICFS, with important theoretical and practical implications for regulators to progressively regulate and promote this form of investor activity.

## Full-text entities

- **Genes:** TUBA3D (tubulin alpha 3d) [NCBI Gene 113457] {aka H2-ALPHA, KTCN9, TUBA2}
- **Diseases:** SV (MESH:D002303), ICFS (MESH:D054318), myopia (MESH:D009216)
- **Chemicals:** PONE-D-23-22387 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10977698/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10977698/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC10977698/full.md

---
Source: https://tomesphere.com/paper/PMC10977698